WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Apr 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-03-31

Reporting Person: WEILAND JOHN H (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-31	Phantom Stock Unit	$	A	362.7920	Acquired		Common Stock (362.7920)	Direct

Footnotes

F1: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.